The adverse reactions, reported regardless of investigator assessment of causality in 5% of patients treated with Januvia 100 mg daily as monotherapy, Januvia in combination with pioglitazone, or Januvia in combination with glimepiride, with or without metformin, and more commonly than in patients treated with placebo, are shown in Table 1
While these features are associated with a LoF phenotype, other studies suggest that both GIPR agonists and antagonists may provide benefits to T2D and obesity (Yang et al., 2022), indicating a complex mechanism of GIPR action within the processes of blood glucose and weight regulation
In the broader population, over 100 million people are classified as having obesity and many of these are now seeking prescriptions for GLP-1 receptor agonists
57 MULTIFOCAL/DIFFUSE PIGMENTATION Physiologic Pigmentation Physiologic pigmentation is the most common multifocal or diffuse oral mucosal pigmentation (Table 54)
Allergic reactions: There could be some allergy associated with the semaglutide